Neurobiology of Disease (Jun 2022)
Immune responses in the Parkinson's disease brain
Abstract
Immune changes occur in all neurodegenerative conditions, but there are significant differences between diseases. For Parkinson's disease (PD), the immune system involvement is still being identified with considerable promise for therapeutic targeting. Post-mortem analyses of PD patient brains and pre-clinical cell and rodent models of PD identify increased inflammation in the brain and an elevation in central and peripheral pro-inflammatory cytokines. The cells involved include activated microglia surrounding degenerating neurons, currently thought to be neuroprotective in early disease stages but detrimental at later stages. Very different astrocytic reactions are found in the PD brain compared to other neurodegenerative conditions, with a loss of normal astrocyte functions contributing to a neurotoxic or dysfunctional phenotype (rather than classical astrogliosis found in all other neurodegenerative conditions). Astrocytes in PD are also actively involved in clearing α-synuclein away from vulnerable neurons, but the eventual accumulation of α-synuclein in their cytoplasm promotes a pro-inflammatory response and contributes to their dysfunctional phenotype and the spreading of PD pathology. Infiltration of peripheral immune cells also occurs in the PD brain, particularly T cells and monocytes. Both CD4 and CD8 T cells occur in regions of cell loss, with cytotoxic CD8 T cells occurring in the earliest stages and CD4 T helper cells occurring with disease progression. Current evidence points towards infiltrating monocytes as also playing a role in neuron death. Further characterisation of the successive molecular changes in both the resident and peripheral immune cells invading the PD brain will provide targets for disease modification.